Vol 8, No 2 (2017)
Research paper
Published online: 2017-09-06

open access

Page views 1724
Article views/downloads 4280
Get Citation

Connect on Social Media

Connect on Social Media

Assessment of nutritional status in patients with myeloid and lymphoid neoplasms, using the PG-SGA score

Agata Lewandowska1, Alicja Elżbieta Woźniak1, Katarzyna Bożena Budziszewska, Joanna Góra-Tybor1, Krzysztof Jamroziak1, Ewa Lech-Marańda1, Krzysztof Warzocha1
Hematologia 2017;8(2):105-112.

Abstract

A dynamic course of hematologic neoplasms as well as intensive chemotherapy are related with development of malnutrition symptoms in a short time. For this reason, it is necessary to perform not only screening procedure but also detailed assessment of nutritional status. The purpose of this research was the assessment of nutritional status and nutritional intervention needs in patients with hematologic neoplasms by PG-SGA score. Most of people (45%) were assigned to category: well malnourished. Next, 43% people were moderately nourished and 11% were severely malnourished. Nutritional intervention was recommended to 83% people, among who 44% indicates a critical need for intervention. The PG-SGA score allows to fully assess actual nutritional status and estimate further changes, what may help to decide on initiation of nutritional therapy.

References

  1. Prockmann S, Ruschel Freitas AH, Gonçalves Ferreira M, et al. Evaluation of diet acceptance by patients with haematological cancer during chemotherapeutic treatment. Nutr Hosp. 2015; 32(2): 779–784.
  2. von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle. 2010; 1(1): 1–5.
  3. Kłęk S. Leczenie żywieniowe w onkologii. Onkol Prakt Klin. 2011; 5: 269–273.
  4. Rozporządzenia ministra zdrowia z dnia 22 listopada 2013 r. w sprawie świadczeń gwarantowanych z zakresu leczenia szpitalnego (Dz. U. z 2008 r. nr 164, poz. 1027, z późn. zm.).
  5. Fizia K, Gętek M, Czech N. Metody oceny stanu odżywienia u chorych na nowotwory. Piel Pol. 2013; 48: 105–110.
  6. Phippen NT, Lowery WJ, Barnett JC, et al. Evaluation of the Patient-Generated Subjective Global Assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: a pilot study. Gynecol Oncol. 2011; 123(2): 360–364.
  7. Talarek M, Szawłowski A. Ogólnopolski program oceny występowania niedożywienia u pacjentów z nowotworami układu pokarmowego I układu oddechowego. Pol Prz Chir. 2007; 79: 343–352.
  8. Tkanka limfatyczna i krwiotwórcza. Krajowy Rejestr Nowotworów. http://onkologia.org.pl/tkanka-limfatyczna-krwiotworcza-c81-c96/ (25.01.2017).
  9. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017; 36(1): 11–48.
  10. Read JA, Choy ST, Beale P, et al. An evaluation of the prevalence of malnutrition in cancer patients attending the outpatient oncology clinic. Asia Pac J Clin Oncol. 2006; 2(2): 80–86.
  11. Malihi Z, Kandiah M, Chan YM, et al. Nutritional status and quality of life in patients with acute leukaemia prior to and after induction chemotherapy in three hospitals in Tehran, Iran: a prospective study. J Hum Nutr Diet. 2013; 26(Suppl 1): 123–131.
  12. Malone MA. Final DNP Practice Inquiry Project Report. Improving nutritional status in the hematologic oncology population. University of Kentucky, College of Nursing, Lexington 2015.
  13. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism. 2011; 60(11): 1500–1510.
  14. Seally MJ, Nijholt W, Stuiver MM. Content validity of methods to assess malnutrition in patients with cancer: a systematic review. ESPEN, Geneva 2014.
  15. Lis CG, Gupta D, Lammersfeld CA, et al. Role of nutritional status in predicting quality of life outcomes in cancer--a systematic review of the epidemiological literature. Nutr J. 2012; 11: 27.
  16. Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer. 2008; 122(6): 1418–1421.
  17. Pawłowska J, Witkowski JM, Bryl E. Zespół metaboliczny — aktualny stan wiedzy o przyczynach i patomechanizmach. Forum Med Rodz. 2009; 3: 278–291.
  18. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348(17): 1625–1638.
  19. Carneiro IP, Mazurak VC, Prado CM. Clinical implications of sarcopenic obesity in cancer. Curr Oncol Rep. 2016; 18(10): 62.
  20. Malihi Z, Kandiah M, Chan YM, et al. The effect of dietary intake changes on nutritional status in acute leukaemia patients after first induction chemotherapy. Eur J Cancer Care (Engl). 2015; 24(4): 542–552.
  21. Lewandowska A, Woźniak AE. Leczenie żywieniowe u chorych na nowotwory układów krwiotwórczego i chłonnego. Hematologia. 2017; 7(3): 243–249.



Hematology in Clinical Practice